Premal Lulla - Concepedia

Author

Premal Lulla

Also Known As

Hassell, Kathryn, Heslop, Helen E., P Lulla, P. D. Lulla, P. Lulla, P.D. Lulla, Premal D Lulla, Premal D. Lulla, Premal Lulla

159

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine Methodist Hospital Texas Children's Hospital Houston Methodist Children's Cancer Center

About

Premal Lulla is an author at Baylor College of Medicine specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	896
2	Cellular Therapies	5	5	537
3	Cell Biology	4	4	77
4	Health Sciences	2	2	48
5	Epidemiology	1	1	36

Premal Lulla

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation Ifigeneia Tzannou, Swati Naik, Kathryn Leung, Journal of Clinical Oncology Bk VirusCell TherapyTransplantationEpstein-barr VirusStem Cell Transplantation	2017	439
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma Carlos A. Ramos, Natalie S. Grover, Anne Beaven, Journal of Clinical Oncology	2020	366
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1 Haruko Tashiro, Tim Sauer, Thomas Shum, Molecular Therapy	2017	153
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia Diogo Gomes‐Silva, Erden Atilla, Pınar Ataca Atilla, Molecular Therapy	2018	150
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers David Steffin, Nisha Ghatwai, Antonino Montalbano, Nature Cancer ImmunosurveillanceSolid CancersMedicineImmunologyImmune Checkpoint Inhibitor	2024	150
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation Pradip Bajgain, Supannikar Tawinwung, Lindsey D’Elia, Journal for ImmunoTherapy of Cancer	2018	102
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry Samantha Jaglowski, Zhen‐Huan Hu, Yiyun Zhang, Blood	2019	78
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting Thomas Pfeiffer, Ifigeneia Tzannou, Meng-Fen Wu, Clinical Cancer Research	2023	76
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant Premal Lulla, Swati Naik, Spyridoula Vasileiou, Blood	2020	63
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas LaQuisa Hill, Rayne H. Rouce, Meng-Fen Wu, Blood	2023	53

Page 1